• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » PAREXEL named a Flexjobs Top 100 Company to Watch For Telecommuting and Remote Jobs

PAREXEL named a Flexjobs Top 100 Company to Watch For Telecommuting and Remote Jobs

March 13, 2017
CenterWatch Staff

PAREXEL International, a global biopharmaceutical services organization, has been named to the FlexJobs Top 100 Companies to Watch for Telecommuting and Remote Jobs in 2017 list for the fourth consecutive year. The list recognizes companies that are telecommuting-friendly, allowing for candidates to telecommute on a full- or part-time basis.

PAREXEL offers approximately 20% of its nearly 20,000 global employees flexible work options, including telecommuting, flexible schedules, and home-based employment. In North America, approximately 40% of PAREXEL’s employees take advantage of the company’s telecommuting and flexible work opportunities. These employees represent a diverse cross section of positions, including clinical research, biostatistics and regulatory affairs.

“We are pleased to be recognized as a leader in providing telecommuting and remote job opportunities,” said Tom McGoldrick, corporate vice president of Talent Acquisition, PAREXEL. “By offering remote and flexible work options, PAREXEL has developed a highly engaged, skilled and satisfied workforce that allows us to continue delivering for our clients and helping them bring new treatments to patients in need.”

“More people are now professionally engaged in the knowledge economy, which naturally supports jobs that can be done from home. And as more companies embrace remote work in meaningful ways, more people will have greater access to broader career and employment opportunities, creating a positive ripple effect on our economy,” said Sara Sutton Fell, founder and CEO of FlexJobs. 

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • MAGI East 2023

    MAGI East 2023 Preview: Janssen Reports on Environmental Impact of Trials

  • Complexity-360x240.png

    Phase 3 Trials Significantly Rising in Complexity, Says CSDD

  • Quality Level Scale

    Build Quality into Trials Like You’d Build a House, Says FDA’s BIMO Director

  • DE&I

    Trust-Building, Community Connection Still Essential to DE&I Efforts, Experts Say

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing